Literature DB >> 22241131

Cotrimoxazole enhances the in vitro susceptibility of Coccidioides posadasii to antifungals.

Rossana de Aguiar Cordeiro1, Delia Jessica Astete-Medrano, Francisca Jakelyne de Farias Marques, Heuziwanne Tavares Leite Andrade, Lauro Vieira Perdigão Neto, Juliane Lira Tavares, Rita Amanda Chaves de Lima, Kharla Kharolyni Nobre Rabelo Patoilo, Andre Jalles Monteiro, Raimunda Sâmia Nogueira Brilhante, Marcos Fábio Gadelha Rocha, Zoilo Pires de Camargo, José Júlio Costa Sidrim.   

Abstract

The aim of the present study was to evaluate the effect of cotrimoxazole on the in vitro susceptibility of Coccidioides posadasii strains to antifungals. A total of 18 strains of C. posadasii isolated in Brazil were evaluated in this study. The assays were performed in accordance with the Clinical and Laboratory Standards Institute guidelines and the combinations were tested using the checkerboard method. The minimum inhibitory concentrations were reduced by 11, 2.4, 4.3 and 3.5 times for amphotericin B, itraconazole, fluconazole and voriconazole, respectively. Moreover, it was seen that cotrimoxazole itself inhibited C. posadasii strains in vitro. The impairment of folic acid synthesis may be a potential antifungal target for C. posadasii.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22241131     DOI: 10.1590/s0074-02762011000800024

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  2 in total

1.  Antifungal therapeutics for dimorphic fungal pathogens.

Authors:  Kristie D Goughenour; Chad A Rappleye
Journal:  Virulence       Date:  2016-09-19       Impact factor: 5.882

2.  Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B.

Authors:  R de Aguiar Cordeiro; C I Mourão; M F G Rocha; F J de Farias Marques; C E C Teixeira; D F de Oliveira Miranda; L V P Neto; R S N Brilhante; T de Jesus Pinheiro Gomes Bandeira; J J C Sidrim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-29       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.